Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

103
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
103
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

90
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
90
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

109
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
109
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

110
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
110
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

117
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
117

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineered iMSCs delivering wild-type IL-2 achieve dose-sparing tumor control via CD25-dependent CD8<sup>+</sup> T-cell activation.

BMC medicine·2026
Same author

Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation.

Journal of translational autoimmunity·2026
Same author

CRISPR-Cas-based live cell imaging of genome dynamics.

Nature reviews. Genetics·2026
Same author

Meta-analysis of the prevalence, serotype distribution, and antimicrobial susceptibility of Salmonella spp. from eggs in China.

International journal of food microbiology·2026
Same author

Multi-tissue transcriptomic aging atlas reveals predictive aging biomarkers in the killifish.

Nature aging·2026
Same author

Deep learning-guided design of cell type-specific AAV promoters.

bioRxiv : the preprint server for biology·2026
Same journal

Author Correction: Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.

Nature cell biology·2026
Same journal

An atlas of primate insular cortex reveals a signal-processing strategy in von Economo neurons.

Nature cell biology·2026
Same journal

Primate neurons with special signalling logic.

Nature cell biology·2026
Same journal

Cell surface liposome binding (CLiB) allows lipid-binding probe engineering via high-throughput screening.

Nature cell biology·2026
Same journal

Mapping the human female reproductive tract.

Nature cell biology·2026
Same journal

Learning from stem cell-based embryo models.

Nature cell biology·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

piggyBac Transposon System Modification of Primary Human T Cells
10:02

piggyBac Transposon System Modification of Primary Human T Cells

Published on: November 5, 2012

18.0K

Programmable macromolecule delivery via engineered trogocytosis.

Xinyi Chen1, Yinglin Situ1, Yuexuan Yang1

  • 1Department of Bioengineering, Stanford University, Stanford, CA, USA.

Nature Cell Biology
|April 1, 2026
PubMed
Summary
This summary is machine-generated.

Engineered cells can transfer proteins to other cells via trogocytosis, a cell-cell contact process. This TRANSFER system enables programmable, versatile, and efficient macromolecular delivery for therapeutic applications.

More Related Videos

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
08:02

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform

Published on: November 7, 2013

13.5K
Delivery of Proteins, Peptides or Cell-impermeable Small Molecules into Live Cells by Incubation with the Endosomolytic Reagent dfTAT
10:30

Delivery of Proteins, Peptides or Cell-impermeable Small Molecules into Live Cells by Incubation with the Endosomolytic Reagent dfTAT

Published on: September 2, 2015

10.8K

Related Experiment Videos

Last Updated: Apr 3, 2026

piggyBac Transposon System Modification of Primary Human T Cells
10:02

piggyBac Transposon System Modification of Primary Human T Cells

Published on: November 5, 2012

18.0K
Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
08:02

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform

Published on: November 7, 2013

13.5K
Delivery of Proteins, Peptides or Cell-impermeable Small Molecules into Live Cells by Incubation with the Endosomolytic Reagent dfTAT
10:30

Delivery of Proteins, Peptides or Cell-impermeable Small Molecules into Live Cells by Incubation with the Endosomolytic Reagent dfTAT

Published on: September 2, 2015

10.8K

Area of Science:

  • Cell Biology
  • Biotechnology
  • Molecular Engineering

Background:

  • Trogocytosis, the transfer of plasma membrane fragments during cell-cell contact, presents opportunities for macromolecular delivery.
  • Current limitations include uncertain cargo fate, restriction to membrane components, and unclear applicability across cell types.

Purpose of the Study:

  • To engineer cells for efficient and functional protein transfer to recipient cells via trogocytosis.
  • To establish key principles for enhancing trogocytosis-mediated delivery.
  • To develop a versatile and programmable cell-based delivery system.

Main Methods:

  • Engineering donor cells with designed receptors for specific surface ligand recognition.
  • Implementing pH-responsive membrane fusion and inducible cargo localization/release mechanisms.
  • Investigating dynamin- and endosome acidification-dependent pathways for cargo transfer.

Main Results:

  • Demonstrated successful protein transfer between engineered cells through direct contact.
  • Identified engineering principles that enhance transfer efficiency and cargo functionalization.
  • Developed TRANSFER, a versatile system with programmable cell specificity and tunability.
  • Showcased TRANSFER's ability to deliver large therapeutic proteins and mediate genome editing.

Conclusions:

  • Trogocytosis can be engineered into a programmable and versatile framework for cell-based macromolecular delivery.
  • The TRANSFER system offers broad applicability across diverse cell types.
  • This approach enables precise control over cargo delivery and therapeutic applications.